EXPERTISE DESIGNED TO ADVANCE HEALTHCARE
Genetics & Genomics Testing
Genetic insights are integral to life and health. Labcorp understands the growing importance of genetic testing in advancing healthcare and meeting your clinical, scientific and business needs.
Genetic testing is profoundly personal.
Our extensive portfolio of tests and services spans screening, diagnostic and drug development needs for genetic testing across the healthcare continuum. By partnering together to leverage the power of advances in genetics, we can reshape healthcare and drive development of and access to targeted therapies that enhance patient outcomes.
Labcorp is your source for genetic insights that will shape the future of healthcare.
400+
genetic tests available across 10 clinical specialty areas
12M+
genetic tests performed
1,200+
MDs and PhDs on our team focused on advancements in testing and breakthrough treatments
150+
genetic counseling team members supporting both patients and clinicians
Genetic insights are key to the advancement of healthcare.
Broad test menu, expert support, accessible testing services and capabilities all designed to meet your needs for genetic testing.
Clinical Testing
From oncology and women’s health to specialty medicine, Labcorp can support you and your patients’ genetic testing needs throughout the continuum of care.
Individual Genetic Testing
Our genetic testing and genetic counseling services help you understand the option that may be best for you.
Nonclinical Research
We partner with hundreds of scientists and researchers from biotech and pharmaceutical companies to help you test, validate and bring to market your next pharmaceutical or medical device product.
Commercial Genetic Services
Through our test development and efficient, high-volume operational capabilities, Labcorp can scale to meet your commercial needs for genetic testing.
Featured Tests
MaterniT® 21 PLUS
A market-leading early pregnancy risk assessment of Down syndrome and other genetic conditions
MaterniT 21 PLUS analyzes genetic information entering the mother’s bloodstream from the placenta to screen for chromosomal abnormalities that could affect the baby’s health and development.
Comprehensive Epilepsy Tests
A comprehensive suite of epilepsy tests and services
Testing for epilepsy-related genes can help clarify diagnosis and prognosis, support optimal treatment selection and reveal important information for family planning. Our broad portfolio also aids evaluating autoimmune epilepsy as well as assessment of epilepsy drug levels in patients.
OmniSeq® INSIGHT
A comprehensive genomic and immune profiling test for solid tumors
Using advanced NGS technology that only requires a single tumor biopsy, OmniSeq INSIGHT provides a deeper understanding of a solid tumor and its microenvironment to support personalized patient care.
IntelliGEN® Myeloid
An NGS-based assay that evaluates 50 genes associated with myeloid malignancies
The IntelliGEN Myeloid panel identifies somatic mutations that can be useful in providing diagnostic, prognostic and predictive information for patients with myeloid malignancies.
Resources
Genetics & Genomics
Poster
-
17 April 2023
Inhibition of murine myeloid suppressor cells increases CD8+T cell activation in vitro
Press Release
-
2 June 2022
Labcorp expands access to comprehensive genomic testing through new lung cancer program
Press Release
-
19 April 2022
Labcorp enhances cell and gene therapy development support through collaboration with Xcell Biosciences
Poster
-
1 March 2022